학술논문
370 Pharmacodynamic assessment of a novel FAP-targeted 4–1BB agonist, administered as single agent and in combination with atezolizumab to patients with advanced solid tumors
Document Type
article
Author
Josep Tabernero; Maurizio Ceppi; Victor Moreno; Michael Hettich; Miguel Sanmamed; Christina Claus; Tatiana Hernandez; Iben Spanggaard; Analia Azaro; Maria Martinez Garcia; Alejo Rodriguez-Vida; Florian Heil; Oliver Krieter; Oliver Grimm; Marta Canamero; Jose Duarte; Alexandra-Cristina Nica; Iakov Davydov; Chia-Huey Ooi; Christian Heichinger; Ernesto Guarin; Radoiane Helbaj; Tamara Tanos; Eveline Nueesch; Irene Moreno
Source
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Subject
Language
English
ISSN
2051-1426